Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non―Small-Cell Lung Cancer: A Phase III Trial
- Author
- SCAGLIOTTI, Giorgio V1 ; KRZAKOWSKI, Maciej2 ; PAPAI, Zsolt S6 ; KARASEVA, Nina8 ; THONGPRASERT, Sumitra14 ; DALMAU PORTULAS, Elsa15 ; PAWEL, Joachim Von11 ; KE ZHANG; SELARU, Paulina; TYE, Lesley; CHAO, Richard C; GOVINDAN, Ramaswamy; SZCZESNA, Aleksandra3 ; STRAUSZ, Janos4 ; MAKHSON, Anatoly7 ; RECK, Martin9 ; WIERZBICKI, Rafal F12 ; ALBERT, Istvan5 ; THOMAS, Michael10 ; ABRAO MIZIARA, Jose Elias13
[1] University of Turin, Orbassano (Turin), Italy
[2] Maria Sklodowska-Curie Memorial Institute of Oncology, Warsaw, Poland
[3] Regional Lung Diseases Hospital, Otwock, Poland
[4] Koranyi National Institute for Pulmonology, Budapest, Hungary
[5] Matrai Gyogyintezet, Matrahaza, Hungary
[6] Fejer Megyei Szent Gyorgy Korhaz, Szekesfehervar, Hungary
[7] Moscow City Clinical Hospital of Oncology #62, Moscow, Russian Federation
[8] City Clinical Oncology Dispensary, St. Petersburg, Russian Federation
[9] Hospital Grosshansdorf, Grosshansdorf, Germany
[10] Thoracic Clinic, University of Heidelberg, Heidelberg, Germany
[11] Asklepios-Fachklinik Munchen-Gauting, Gauting, Germany
[12] R.S. McLaughlin Durham Regional Cancer Centre, Lakeridge Health, Oshawa, Ontario, Canada
[13] Hospital de Cancer de Barretos, Barretos, Brazil
[14] Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
[15] Corporacio Pare Tauli, Hospital de Sabadell, Barcelona, Spain - Source
Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2070-2078, 9 p ; ref : 19 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- American Society of Clinical Oncology, Alexandria, VA
- Publication country
- United States
- Document type
- Article
- Language
- Russian
- Keyword (fr)
- Antiangiogénique Anticancéreux Association médicamenteuse Cancer du poumon Cancérologie Carcinome non petite cellule bronchopulmonaire Chimiothérapie Erlotinib Essai clinique phase III Etude comparative Homme Placebo Stade avancé Sunitinib Traitement Anti-EGFR Cancer Dérivé de la quinazoline Enzyme Inhibiteur de la tyrosine kinase Inhibiteur enzyme Inhibiteur multikinase Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons Protein-tyrosine kinase Transferases Tumeur maligne
- Keyword (en)
- Antiangiogenic agent Antineoplastic agent Drug combination Lung cancer Cancerology non-small cell lung carcinoma Chemotherapy Erlotinib Phase III trial Comparative study Human Placebo Advanced stage Sunitinib Treatment Cancer Quinazoline derivatives Enzyme Tyrosine kinase inhibitor Enzyme inhibitor Multikinase inhibitor Respiratory disease Bronchus disease Lung disease Protein-tyrosine kinase Transferases Malignant tumor
- Keyword (es)
- Antiangiogenico Anticanceroso Asociación medicamentosa Cáncer del pulmón Cancerología Carcinoma no pequeňa célula bronchopulmonar Quimioterapia Erlotinib Ensayo clínico fase III Estudio comparativo Hombre Placebo Estadio avanzado Sunitinib Tratamiento Cáncer Enzima Inhibidor tyrosine kinase Inhibidor enzima inhibidor multicinasa Aparato respiratorio patología Bronquio patología Pulmón patología Protein-tyrosine kinase Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25982637
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2011.39.2993 
https://dx.doi.org/10.1200/JCO.2011.39.2993
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.39.2993\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non\u2015Small-Cell Lung Cancer: A Phase III Trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:2:\"17\";s:8:\"\u0000*\u0000spage\";s:4:\"2070\";s:8:\"\u0000*\u0000epage\";s:4:\"2078\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"SCAGLIOTTI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Giorgio V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:18:\"KRZAKOWSKI, Maciej\";i:1;s:14:\"PAPAI, Zsolt S\";i:2;s:14:\"KARASEVA, Nina\";i:3;s:21:\"THONGPRASERT, Sumitra\";i:4;s:21:\"DALMAU PORTULAS, Elsa\";i:5;s:18:\"PAWEL, Joachim Von\";i:6;s:8:\"KE ZHANG\";i:7;s:15:\"SELARU, Paulina\";i:8;s:11:\"TYE, Lesley\";i:9;s:15:\"CHAO, Richard C\";i:10;s:19:\"GOVINDAN, Ramaswamy\";i:11;s:20:\"SZCZESNA, Aleksandra\";i:12;s:14:\"STRAUSZ, Janos\";i:13;s:16:\"MAKHSON, Anatoly\";i:14;s:12:\"RECK, Martin\";i:15;s:19:\"WIERZBICKI, Rafal F\";i:16;s:14:\"ALBERT, Istvan\";i:17;s:15:\"THOMAS, Michael\";i:18;s:25:\"ABRAO MIZIARA, Jose Elias\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non\u2015Small-Cell Lung Cancer: A Phase III Trial\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.39.2993\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non\u2015Small-Cell Lung Cancer: A Phase III Trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:2:\"17\";s:8:\"\u0000*\u0000spage\";s:4:\"2070\";s:8:\"\u0000*\u0000epage\";s:4:\"2078\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"SCAGLIOTTI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Giorgio V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:18:\"KRZAKOWSKI, Maciej\";i:1;s:14:\"PAPAI, Zsolt S\";i:2;s:14:\"KARASEVA, Nina\";i:3;s:21:\"THONGPRASERT, Sumitra\";i:4;s:21:\"DALMAU PORTULAS, Elsa\";i:5;s:18:\"PAWEL, Joachim Von\";i:6;s:8:\"KE ZHANG\";i:7;s:15:\"SELARU, Paulina\";i:8;s:11:\"TYE, Lesley\";i:9;s:15:\"CHAO, Richard C\";i:10;s:19:\"GOVINDAN, Ramaswamy\";i:11;s:20:\"SZCZESNA, Aleksandra\";i:12;s:14:\"STRAUSZ, Janos\";i:13;s:16:\"MAKHSON, Anatoly\";i:14;s:12:\"RECK, Martin\";i:15;s:19:\"WIERZBICKI, Rafal F\";i:16;s:14:\"ALBERT, Istvan\";i:17;s:15:\"THOMAS, Michael\";i:18;s:25:\"ABRAO MIZIARA, Jose Elias\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non\u2015Small-Cell Lung Cancer: A Phase III Trial\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.39.2993\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.39.2993\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non\u2015Small-Cell Lung Cancer: A Phase III Trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:2:\"17\";s:8:\"\u0000*\u0000spage\";s:4:\"2070\";s:8:\"\u0000*\u0000epage\";s:4:\"2078\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"SCAGLIOTTI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Giorgio V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:18:\"KRZAKOWSKI, Maciej\";i:1;s:14:\"PAPAI, Zsolt S\";i:2;s:14:\"KARASEVA, Nina\";i:3;s:21:\"THONGPRASERT, Sumitra\";i:4;s:21:\"DALMAU PORTULAS, Elsa\";i:5;s:18:\"PAWEL, Joachim Von\";i:6;s:8:\"KE ZHANG\";i:7;s:15:\"SELARU, Paulina\";i:8;s:11:\"TYE, Lesley\";i:9;s:15:\"CHAO, Richard C\";i:10;s:19:\"GOVINDAN, Ramaswamy\";i:11;s:20:\"SZCZESNA, Aleksandra\";i:12;s:14:\"STRAUSZ, Janos\";i:13;s:16:\"MAKHSON, Anatoly\";i:14;s:12:\"RECK, Martin\";i:15;s:19:\"WIERZBICKI, Rafal F\";i:16;s:14:\"ALBERT, Istvan\";i:17;s:15:\"THOMAS, Michael\";i:18;s:25:\"ABRAO MIZIARA, Jose Elias\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non\u2015Small-Cell Lung Cancer: A Phase III Trial\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.39.2993\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non\u2015Small-Cell Lung Cancer: A Phase III Trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:2:\"17\";s:8:\"\u0000*\u0000spage\";s:4:\"2070\";s:8:\"\u0000*\u0000epage\";s:4:\"2078\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"SCAGLIOTTI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Giorgio V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:18:\"KRZAKOWSKI, Maciej\";i:1;s:14:\"PAPAI, Zsolt S\";i:2;s:14:\"KARASEVA, Nina\";i:3;s:21:\"THONGPRASERT, Sumitra\";i:4;s:21:\"DALMAU PORTULAS, Elsa\";i:5;s:18:\"PAWEL, Joachim Von\";i:6;s:8:\"KE ZHANG\";i:7;s:15:\"SELARU, Paulina\";i:8;s:11:\"TYE, Lesley\";i:9;s:15:\"CHAO, Richard C\";i:10;s:19:\"GOVINDAN, Ramaswamy\";i:11;s:20:\"SZCZESNA, Aleksandra\";i:12;s:14:\"STRAUSZ, Janos\";i:13;s:16:\"MAKHSON, Anatoly\";i:14;s:12:\"RECK, Martin\";i:15;s:19:\"WIERZBICKI, Rafal F\";i:16;s:14:\"ALBERT, Istvan\";i:17;s:15:\"THOMAS, Michael\";i:18;s:25:\"ABRAO MIZIARA, Jose Elias\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non\u2015Small-Cell Lung Cancer: A Phase III Trial\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.39.2993\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non\u2015Small-Cell Lung Cancer: A Phase III Trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:2:\"17\";s:8:\"\u0000*\u0000spage\";s:4:\"2070\";s:8:\"\u0000*\u0000epage\";s:4:\"2078\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"SCAGLIOTTI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Giorgio V\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:18:\"KRZAKOWSKI, Maciej\";i:1;s:14:\"PAPAI, Zsolt S\";i:2;s:14:\"KARASEVA, Nina\";i:3;s:21:\"THONGPRASERT, Sumitra\";i:4;s:21:\"DALMAU PORTULAS, Elsa\";i:5;s:18:\"PAWEL, Joachim Von\";i:6;s:8:\"KE ZHANG\";i:7;s:15:\"SELARU, Paulina\";i:8;s:11:\"TYE, Lesley\";i:9;s:15:\"CHAO, Richard C\";i:10;s:19:\"GOVINDAN, Ramaswamy\";i:11;s:20:\"SZCZESNA, Aleksandra\";i:12;s:14:\"STRAUSZ, Janos\";i:13;s:16:\"MAKHSON, Anatoly\";i:14;s:12:\"RECK, Martin\";i:15;s:19:\"WIERZBICKI, Rafal F\";i:16;s:14:\"ALBERT, Istvan\";i:17;s:15:\"THOMAS, Michael\";i:18;s:25:\"ABRAO MIZIARA, Jose Elias\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non\u2015Small-Cell Lung Cancer: A Phase III Trial\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
